alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
FACT SHEET

For more information, visit CBP.gov or contact the Office of Public Affairs at 202-344-1770. 11/15

The Free and Secure Trade program, or FAST, is a 

commercial clearance program for known lowrisk shipments entering the U.S. from Canada and 

Mexico. Initiated after 9/11, this innovative trusted 

traveler/trusted shipper program allows expedited 

processing for commercial carriers who have 

completed background checks and fulfill certain 

eligibility requirements. 

More than 75,000 commercial drivers are enrolled 

in the FAST program nationwide. FAST enrollment 

is open to truck drivers from the U.S., Canada, and 

Mexico. 

FAST vehicle lanes process cargo at land border 

ports of entry that serve commercial cargo on 

both the northern and southern land border. 

The majority of dedicated FAST lanes are located 

at northern border ports in Michigan, New York 

and Washington state and at southern border ports 

from California to Texas. 

Participation in FAST requires that every link in 

the supply chain, from manufacturer to carrier to 

driver to importer, is certified under the CustomsTrade Partnership Against Terrorism program, or 

C-TPAT. 

C-TPAT is a voluntary government-private sector 

partnership that establishes clear supply chain 

security criteria for members to meet and in return 

provides incentives and benefits, like expedited 

processing. 

CBP routinely conducts onsite visits to domestic 

and foreign C-TPAT member facilities to evaluate 

and validate their supply chain security measures. 

More than 10,000 companies worldwide are certified C-TPAT members. Applications for C-TPAT certification can be filed online at CBP.gov.

Applications for FAST can be completed and submitted at the GOES website. https://goes-app.cbp.

dhs.gov

The cost to apply for FAST membership is $50 U.S. 

or Canadian for five years. 

Among the key benefits of FAST enrollment are: 

■ Access to dedicated lanes for greater speed and 

efficiency in processing transborder shipments; 

■ Reduced number of inspections, resulting in 

reduced delays at the border; 

■ Priority, front-of-the-line processing for CBP 

inspections; and,

■ Enhanced supply chain security while promoting 

the economic prosperity of the U.S., Canada and 

Mexico. n

Free and Secure Trade Program 

(FAST)

CBP Publication No. 2117-1115
[No. 39453-3-I.

Division One.

November 24, 1997.]

#### The State of Washington, *Respondent,*v. David John Holmes, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 95-1-07958-6, George T. Mattson, J., entered September 3, 1996. *Affirmed*by unpublished per curiam opinion.
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.818 Oxystearin. The food additive oxystearin may be safely used in foods, when such use is not precluded by standards of identity in accordance with the following conditions: ( a ) The additive is a mixture of the glycerides of partially oxidized stearic and other fatty acids obtained by heating hydrogenated cottonseed or soybean oil under controlled conditions, in the presence of air and a suitable catalyst which is not a food additive as so defined. The resultant product meets the following specifications: Acid number: Maximum 15. Iodine number: Maximum 15. Saponification number: 225-240. Hydroxyl number: 30-45. Unsaponifiable material: Maximum 0.8 percent. Refractive index (butyro): 60±1 at 48 °C.
( b ) It is used or intended for use as a crystallization inhibitor in vegetable oils and as a release agent in vegetable oils and vegetable shortenings, whereby the additive does not exceed 0.125 percent of the combined weight of the oil or shortening.
( c ) To insure safe use of the additive, the label and labeling of the additive container shall bear, in addition to the other information required by the Act: ( 1 ) The name of the additive.
( 2 ) Adequate directions to provide an oil or shortening that complies with the limitations prescribed in paragraph (b) of this section.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          37,267
<SECURITIES>                                         0
<RECEIVABLES>                                   11,068
<ALLOWANCES>                                   (1,287)
<INVENTORY>                                     11,406
<CURRENT-ASSETS>                                64,110
<PP&E>                                          48,071
<DEPRECIATION>                                (21,777)
<TOTAL-ASSETS>                                 100,660
<CURRENT-LIABILITIES>                           11,186
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            96
<OTHER-SE>                                      89,232
<TOTAL-LIABILITY-AND-EQUITY>                   100,660
<SALES>                                        107,494
<TOTAL-REVENUES>                               107,494
<CGS>                                           84,240
<TOTAL-COSTS>                                   23,575
<OTHER-EXPENSES>                                 (551)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 155
<INCOME-PRETAX>                                     75
<INCOME-TAX>                                   (1,688)
<INCOME-CONTINUING>                              1,763
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,763
<EPS-BASIC>                                       0.19
<EPS-DILUTED>                                     0.18


</TABLE>
§ 333.160 Labeling of permitted combinations of active ingredients. Statements of identity, indications, warnings, and directions for use, respectively, applicable to each ingredient in the product may be combined to eliminate duplicative words or phrases so that the resulting information is clear and understandable. ( a ) *Statement of identity.* For a combination drug product that has an established name, the labeling of the product states the established name of the combination drug product, followed by the statement of identity for each ingredient in the combination, as established in the statement of identity sections of the applicable OTC drug monographs. For a combination drug product that does not have an established name, the labeling of the product states the statement of identity for each ingredient in the combination, as established in the statement of identity sections of the applicable OTC drug monographs.
( b ) *Indications.* The labeling of the product states, under the heading “Indications,” the indication(s) for each ingredient in the combination, as established in the “Indications” sections of the applicable OTC drug monographs, unless otherwise stated in this paragraph. Other truthful and nonmisleading statements, describing only the indications for use that have been established and listed in this paragraph (b), may also be used, as provided in § 330.1(c)(2), subject to the provisions of section 502 of the act relating to misbranding and the prohibition in section 301(d) of the act against the introduction or delivery for introduction into interstate commerce of unapproved new drugs in violation of section 505(a) of the act. ( 1 ) *For permitted combinations identified in § 333.120(a) .* The indications in § 333.150 should be used.
( 2 ) *For permitted combinations identified in § 333.120(b) .* In addition to the required indication identified in § 333.150, the labeling of the product may state, under the heading “Indications,” the following additional indication: “First aid for the temporary relief of” (select one of the following: “pain,” “discomfort,” “pain or discomfort” or “pain and itching”) “in minor cuts, scrapes, and burns.”
( c ) *Warnings.* The labeling of the product states, under the heading “Warnings,” the warning(s) for each ingredient in the combination, as established in the warnings sections of the applicable OTC drug monographs.
( d ) *Directions.* The labeling of the product states, under the heading “Directions,” directions that conform to the directions established for each ingredient in the directions sections of the applicable OTC drug monographs. When the time intervals or age limitations for administrations of the individual ingredients differ, the directions for the combination product may not exceed any maximum dosage limits established for the individual ingredients in the applicable OTC drug monograph.
[No. 39542-4-I.

Division One.

January 26, 1998.]

#### The State of Washington, *Respondent,*v. Debra Haddix, et al., *Defendants,*George J. Felder, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-1-03594-3, Ricardo S. Martinez, J., entered October 21, 1996. *Affirmed*by unpublished per curiam opinion.
alv-ex102_154.htm



Exhibit 10.2

 

AMENDMENT TO THE

AUTOLIV, INC. 1997 STOCK INCENTIVE PLAN, 

AS AMENDED AND RESTATED AS OF MAY 6, 2009

 

This Amendment to the Autoliv, Inc. 1997 Stock Incentive Plan, as amended and restated as of May 6, 2009, as such plan has been amended from time to time (the “Plan”), is hereby adopted by the Compensation Committee of the Board of Directors of Autoliv, Inc. (the “Corporation”) as of April 24, 2017.  

 

1.The Plan is hereby amended, effective as of January 1, 2017, by deleting in its entirety the definition of “Participant” in Section 2 and replacing it with the following:

 

“Participant” means any key employee or non-employee director of the Company or an Affiliate selected by the Committee and granted an award under the Plan; provided, however, that a non-employee director shall only be eligible to receive full-value stock awards of fully-vested shares of Common Stock granted in satisfaction of payment of all or a portion of his or her annual base retainer for service on the Board.” 

 

2.Except as expressly amended hereby, the terms of the Plan shall be and remain unchanged and the Plan as amended hereby shall remain in full force and effect.

 

IN WITNESS WHEREOF, the Corporation has caused this Amendment to be executed by its duly authorized representative on the day and year first above written.

 


	
AUTOLIV, INC.

	
 
	
 
	
 

	
By:
	
 
	
/s/ Karin Eliasson

	
Authorized Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7313 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7313

 To require the Secretary of Defense to brief Congress on progress in 
     capturing the leadership of the Jalisco New Generation Cartel.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 9, 2024

 Mr. Luttrell introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
 To require the Secretary of Defense to brief Congress on progress in 
     capturing the leadership of the Jalisco New Generation Cartel.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Jalisco Cartel Neutralization Act''.

SEC. 2. CONGRESSIONAL BRIEFINGS ON THE DECAPITATION OF THE JALISCO NEW 
              GENERATION CARTEL.

    (a) Briefing Requirement.--Not later than 90 days after the date of 
enactment of this Act, and every 90 days thereafter, the Secretary of 
Defense shall provide a briefing to the appropriate committees of 
Congress on progress in capturing or killing the leadership of the 
Jalisco New Generation Cartel, also known as Cartel Jalisco Nueva 
Generacion.
    (b) Appropriate Committees of Congress.--In this section, the term 
``appropriate committees of Congress'' means--
            (1) the Committee on the Judiciary, the Committee on Armed 
        Service, the Committee on Foreign Relations, the Committee on 
        Homeland Security and Governmental Affairs, and the Select 
        Committee on Intelligence of the Senate; and
            (2) the Committee on the Judiciary, the Committee on Armed 
        Service, the Committee on Foreign Affairs, the Committee on 
        Homeland Security, and the Permanent Select Committee on 
        Intelligence of the House of Representatives.
                                 <all>
```
```

[Federal Register Volume 75, Number 35 (Tuesday, February 23, 2010)]
[Notices]
[Pages 8084-8085]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3455]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Dental and Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel; Special Emphasis Panel to Review 
NIDCR EUREKA Applications (RFA-GM-10-009).
    Date: March 26, 2010.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Rebecca Wagenaar Miller, Ph.D., Scientific 
Review Officer, Scientific Review Branch, National Inst of Dental & 
Craniofacial Research National Institutes of Health, 6701 Democracy, 
Rm 666, Bethesda, MD 20892, 301-594-0652, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)

[[Page 8085]]

    Dated: February 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3455 Filed 2-22-10; 8:45 am]
BILLING CODE 4140-01-P
```
[No. 39838-5-I.

Division One.

December 1, 1997.]

#### The State of Washington, *Respondent,*v. S.D., *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-8-05979-1, Donald D. Haley, J., entered November 5, 1996. *Reversed*by unpublished per curiam opinion.
I 

118TH CONGRESS 

2D SESSION H. R. 7336 

To amend title 1, United States Code, to provide that, for the purpose 

of determining eligibility for Federal funds, the District of Columbia 

shall be treated as a State and any political subdivision of a State 

or unit of local government, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 13, 2024 

Ms. NORTON introduced the following bill; which was referred to the 

Committee on the Judiciary 

A BILL 

To amend title 1, United States Code, to provide that, for 

the purpose of determining eligibility for Federal funds, 

the District of Columbia shall be treated as a State 

and any political subdivision of a State or unit of local 

government, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Equal Federal Fund5 ing for the District of Columbia Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7336 IH

1 SEC. 2. TREATMENT OF THE DISTRICT OF COLUMBIA AS 

2 STATE AND ANY POLITICAL SUBDIVISION OF 

3 STATE OR UNIT OF LOCAL GOVERNMENT FOR 

4 PURPOSES OF FEDERAL FUNDING. 

5 (a) IN GENERAL.—Chapter 1 of title 1, United 

6 States Code, is amended by adding at the end the fol7 lowing: 

8 ‘‘§ 9. District of Columbia treated as State and polit9 ical subdivision of State or unit of local 

10 government 

11 ‘‘In determining eligibility for Federal funds or relat12 ing to the use of Federal funds, the District of Columbia 

13 shall be treated as a State and as any political subdivision 

14 of a State or unit of local government, unless otherwise 

15 provided.’’. 

16 (b) CLERICAL AMENDMENT.—The table of sections 

17 for such chapter is amended by adding at the end the fol18 lowing: 

‘‘9. District of Columbia treated as State and political subdivision of State or 

unit of local government.’’. 

19 (c) EFFECTIVE DATE.—The amendments made by 

20 this Act shall take effect on October 1, 2025. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
#### The People of the State of New York, Respondent, v. John Bernard Brennan, Appellant.

Sweeney, J.

Appeal from an order of the County Court of Cortland County, entered Hay 9, 1969, which denied defendant’s application for a writ of error *coram nobis,*without a hearing. On April 13, 1966 defendant was indicted for murder in the first degree for allegedly killing his wife. He contends that he entered a plea of not guilty by reason of insanity. The record, however, discloses only a plea of not guilty. Pursuant to section 722-c of the County Law, defendant was granted authority at county expense to retain the services of a psychiatrist for examination. There is nothing in the record to indicate whether this was done. Thereafter defendant was examined by two psychiatrists pursuant to an order as provided by section 658 of the Code of Criminal Procedure. He was found to be sufficiently capable of understanding the charge and of making his defense, and thereafter he pled guilty to manslaughter in the first degree. It is defendant’s sole contention on this appeal that the court erred in failing to hold a hearing on his competency prior to accepting his plea of guilty. We do not agree with this contention. The cases relied upon by the defendant are distinguishable. In each of these cases there was some evidence of the fact of insanity. In the instant ease there is no evidence or allegation of fact in the moving papers that defendant had or has any history of mental illness or insanity prior to, at the time of, or subsequent to his plea. Consequently, the court below properly denied the application. *(People*v. *Smyth,*3 N Y 2d 184; *People*v. *Jor dam,*27 A D 2d 586.) Order affirmed. Reynolds, J. P., Aulisi, Greenblott, Cooke and Sweeney, JJ., concur in memorandum by Sweeney, J.
### {In Archive} Re: Conference Call Shaheerah Kelly to: Wilson Laughter 04/04/2006 01:47 PM Cc: Charlene Nelson, "Rachel G. Misra"

From: Shaheerah Kelly/R9/USEPA/US
To: Wilson Laughter <wilsonlaughter@navajo.org>,
Cc: Charlene Nelson <charlenenelson@navajo.org>, "Rachel G. Misra" <rachelgmisra@navajo.org> Archive: This message is being viewed in an archive.

Thanks, Wilson. I will check with the appropriate people here regarding the date and get back to you.

Shaheerah Kelly U S EPA Region 9 75 Hawthorne Street San Francisco, CA 94105 Phone: 415-947-4156 Fax: 415-947-3579 Wilson Laughter <wilsonlaughter@navajo.org>

Wilson Laughter <wilsonlaughter@navajo.org>
04/04/2006 01:36 PM To Shaheerah Kelly/R9/USEPA/US@EPA

cc "Rachel G. Misra" <rachelgmisra@navajo.org>, Charlene Nelson <charlenenelson@navajo.org> Subject Conference Call

Hi Shaheerah:

The afternoon of April 17 is good for us. We anticipate on having Charlene Nelson, Rachel Misra, and myself on this conference call. If this works out for you too, we can make arrangements for that afternoon.

Wilson NNAQCP

From: Kelly.Shaheerah@epamail.epa.gov [ mailto:Kelly.Shaheerah@epamail.epa.gov] Sent: Mon 3 /

27 / 2006 10:55 A M To: Charlene Nelson Cc: Wilson Laughter; stephenetsitty@navajo.org Subject: Conference Call

Hi, Charlene. This is a follow-up to our phone conversation. We will be having a telephone conference call with ExxonMobil, who is the current owner of the McElmo Creek Unit on the Navajo Reservation. The purpose ofthe call is to discuss some issues regarding the drafting of the company's Title V permit. Some possible dates that we will have the call are April 4, 5, 6, or 7th. Please let me know of your availability on these days and who from Navajo EPA will be joining in on the call. Feel free to contact me if you have any questions. Thanks.

Shaheerah Kelly U S EPA Region 9 75 Hawthorne Street San Francisco, CA 94105 Phone: 415-947-4156 Fax: 415-947-3579
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7385 Enrolled Bill (ENR)]

        H.R.7385

                     One Hundred Eighteenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

         Begun and held at the City of Washington on Wednesday,
         the third day of January, two thousand and twenty-four

                                 An Act

 
To designate the facility of the United States Postal Service located at 
    29 Franklin Street in Petersburg, Virginia, as the ``John Mercer 
                    Langston Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. JOHN MERCER LANGSTON POST OFFICE BUILDING.
    (a) Designation.--The facility of the United States Postal Service 
located at 29 Franklin Street in Petersburg, Virginia, shall be known 
and designated as the ``John Mercer Langston Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``John 
Mercer Langston Post Office Building''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
IN THE SUPREME COURT OF PENNSYLVANIA

In the Matter of

EDWARD HARRINGTON HEYBURN

:

:

:

:

:

:

:

:

:

:

No. 2964 Disciplinary Docket No. 3

No. 35 DB 2023

(Supreme Court of New Jersey, D-111 

September Term 2021)

Attorney Registration No. 80472

(Out of State)

ORDER

PER CURIAM

AND NOW, this 3

rd day of May, 2023, having failed to respond to a Notice and Order 

directing him to provide reasons against the imposition of reciprocal discipline, Edward 

Harrington Heyburn is suspended from the practice of law in the Commonwealth of 

Pennsylvania for a period of 2 years, consecutive to the 18-month term of suspension 

ordered by this Court on October 5, 2022. He shall comply with the provisions of Pa.R.D.E. 

217.